POMDOCTOR LIMITED (POM) Key Metrics
POM key metrics, 2016–2025
Fiscal year ended December 31, 2025 · Chinese yuanPOM returns How much profit the business earns on the capital it uses.
Return on assets−21.7 pts
−276.5%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin−32.7 pts
−37.4%
2025 · hover or tap a bar for each year
20162025
Asset turnover−14.6%
5.20
2025 · hover or tap a bar for each year
20162025
POM financial health Debt, liquidity and how easily interest is covered.
Net debt+CN¥11.9M
CN¥445.4M
2025 · hover or tap a bar for each year
20162025
Current ratio+129.9%
0.48
2025 · hover or tap a bar for each year
20162025
Interest coverage
-9.0
2025 · hover or tap a bar for each year
20162025
Debt / assets−55.7%
4.23
2025 · hover or tap a bar for each year
20162025
POM efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−7 days
18 days
2025 · hover or tap a bar for each year
20162025
Days of inventory−4 days
9 days
2025 · hover or tap a bar for each year
20162025
Days payables outstanding−5 days
37 days
2025 · hover or tap a bar for each year
20162025
Cash conversion cycle−7 days
-10 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue+0.2 pts
0.3%
2025 · hover or tap a bar for each year
20162025
POM returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
POM debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
POM cash returned to shareholders
DividendsBuybacksFree cash flow
POM key metrics in Chinese yuan
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | — | — | — | 17.8% | 1.3% | 9.7% | 7.5% |
| Return on invested capital (ROIC) | — | — | — | — | — | — | 9.0% | 5.8% | 7.1% | 5.7% |
| Return on assets (ROA) | −276.5% | −254.8% | −253.0% | −369.5% | −389.3% | −7.5% | 4.8% | 0.3% | 2.3% | 1.7% |
| Return on tangible assets | −197.6% | −310.1% | −219.3% | −258.2% | −975.6% | −634.3% | 44.9% | 0.4% | 2.4% | 1.0% |
| Free cash flow margin | −37.4% | −4.7% | −15.1% | −9.0% | −7.3% | −24.6% | 0.2% | 2.9% | −0.3% | −0.3% |
| Income quality (OCF / net income) | — | — | — | — | — | — | 0.03 | 21.72 | 2.78 | 7.45 |
| Financial health | ||||||||||
| Total debt | CN¥454.9M | CN¥441.1M | CN¥413.3M | CN¥361.2M | CN¥341.3M | CN¥114.4M | CN¥674.0M | CN¥35.42B | CN¥34.26B | CN¥34.01B |
| Cash & short-term investments | CN¥9.6M | CN¥7.7M | CN¥6.7M | CN¥2.5M | CN¥2.2M | CN¥12.3M | CN¥163.0M | CN¥2.15B | CN¥1.87B | CN¥1.55B |
| Net debt | CN¥445.4M | CN¥433.5M | CN¥406.6M | CN¥358.8M | CN¥339.1M | CN¥102.2M | CN¥511.0M | CN¥33.27B | CN¥32.39B | CN¥32.45B |
| Debt / equity | — | — | — | — | — | — | 0.21 | 1.15 | 1.15 | 1.32 |
| Debt / assets | 4.23 | 9.54 | 6.23 | 7.43 | 17.67 | 1.48 | 0.10 | 0.30 | 0.29 | 0.30 |
| Net debt / EBITDA | — | — | — | — | — | — | 0.10 | 4.15 | 3.40 | 3.62 |
| Current ratio | 0.48 | 0.21 | 0.35 | 0.33 | 0.17 | 0.08 | 0.99 | 1.17 | 1.10 | 0.92 |
| Quick ratio | 0.44 | 0.16 | 0.27 | 0.28 | 0.09 | 0.06 | 0.99 | 1.16 | 1.08 | 0.91 |
| Interest coverage | -9.0 | -2.0 | -1.6 | -0.2 | -4.9 | -17.2 | 2.7 | 2.5 | 2.8 | 2.1 |
| Working capital | −CN¥113.2M | −CN¥141.6M | −CN¥112.6M | −CN¥95.9M | −CN¥91.0M | −CN¥303.6M | −CN¥8.0M | CN¥1.96B | CN¥1.04B | −CN¥1.04B |
| Invested capital | −CN¥8.6M | −CN¥1.83B | −CN¥1.71B | −CN¥1.62B | −CN¥1.51B | −CN¥207.2M | CN¥3.78B | CN¥64.03B | CN¥62.25B | CN¥58.29B |
| Tangible asset value | −CN¥481.3M | −CN¥2.09B | −CN¥1.96B | −CN¥1.90B | −CN¥1.78B | −CN¥346.4M | CN¥3.27B | CN¥24.09B | CN¥23.18B | CN¥19.16B |
| Net current asset value | −CN¥483.9M | −CN¥2.10B | −CN¥1.97B | −CN¥1.90B | −CN¥1.78B | −CN¥360.7M | −CN¥2.75B | −CN¥75.54B | −CN¥75.01B | −CN¥76.66B |
| Capital allocation | ||||||||||
| Share buybacks (net) | — | — | — | — | — | — | — | CN¥1.35B | CN¥898.0M | CN¥635.0M |
| Dividends + buybacks / free cash flow | — | — | — | — | — | — | — | 128.5% | — | — |
| Capex / revenue | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 21.1% | 22.6% | 27.3% |
| Capex / operating cash flow | — | — | — | — | — | — | 0.0% | 87.9% | 101.4% | 101.3% |
| Capex / depreciation | 6.75 | 0.28 | 1.00 | — | 0.00 | 0.00 | 0.00 | 1.27 | 1.40 | 1.53 |
| Stock-based compensation / revenue | 4.1% | 0.0% | 0.0% | — | — | — | — | — | — | — |
| R&D / revenue | 3.2% | 0.9% | 1.1% | 1.5% | 2.0% | 1.4% | — | — | — | — |
| SG&A / revenue | 39.0% | 19.9% | 18.4% | 22.4% | 47.8% | 206.9% | — | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | 18.2 | 25.2 | 35.7 | 20.8 | 1.8 | 3.6 | — | 45.7 | 46.6 | 29.1 |
| Days of inventory on hand | 9.2 | 13.5 | 14.3 | 15.6 | 16.4 | 27.2 | — | 3.3 | 4.0 | 4.3 |
| Days payables outstanding | 36.8 | 41.5 | 58.3 | 70.7 | 63.2 | 275.3 | 46.0 | 80.3 | 90.7 | 52.2 |
| Cash conversion cycle (days) | -9.5 | -2.7 | -8.3 | -34.2 | -44.9 | -244.4 | — | -31.3 | -40.0 | -18.8 |
| Receivables turnover | 20.10 | 14.47 | 10.22 | 17.52 | 200.50 | 100.23 | — | 7.99 | 7.84 | 12.55 |
| Payables turnover | 9.91 | 8.80 | 6.26 | 5.16 | 5.78 | 1.33 | 7.93 | 4.55 | 4.03 | 6.99 |
| Inventory turnover | 39.85 | 26.98 | 25.48 | 23.34 | 22.25 | 13.41 | — | 111.13 | 90.26 | 84.27 |
| Asset turnover | 5.20 | 6.09 | 5.31 | 7.22 | 4.45 | 0.04 | 0.54 | 0.30 | 0.29 | 0.48 |
| Average receivables | CN¥19.9M | CN¥23.7M | CN¥29.8M | CN¥14.0M | CN¥1.1M | CN¥1.4M | — | CN¥4.50B | CN¥4.28B | CN¥2.50B |
| Average payables | CN¥35.1M | CN¥33.5M | CN¥42.5M | CN¥36.9M | CN¥28.2M | CN¥66.0M | CN¥1.95B | CN¥3.67B | CN¥3.49B | CN¥1.81B |
| Average inventory | CN¥8.7M | CN¥10.9M | CN¥10.4M | CN¥8.2M | CN¥7.3M | CN¥6.5M | — | CN¥150.0M | CN¥155.5M | CN¥150.0M |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 47.8% | 0.0% | 5.6% | 5.7% | 5.8% |
Computed from POM's annual financial statements (latest annual report filed May 14, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in Chinese yuan; data from EODHD. Averages use the opening and closing balance of each year.
POM valuation and financial ratios
It ended the year with CN¥454.9 million of debt and CN¥9.6 million in cash and short-term investments, net debt of CN¥445.4 million.
See the POM income statement, the POM chart for price history, or the POM stock overview for the latest quote and news.
POM key metrics FAQ
How much debt does POMDOCTOR LIMITED have?
POMDOCTOR LIMITED had total debt of CN¥454.9 million at the end of fiscal 2025.
What is POMDOCTOR LIMITED's current ratio?
POMDOCTOR LIMITED's current ratio was 0.48 at the end of fiscal 2025: current assets were 0.48 times current liabilities.